How To Build If…It’s Time To Build?

When major tech companies are not in the mix as acquirors, exit multiples tend to be significantly lower.

Turns out research, development, manufacturing, and distribution of physical products is capital intensive, and that alone has kept a lot of early stage capital away from investing in such ideas. A decade or so ago, biotech early stage investors innovated by blending Series As and Bs into one bigger financing round to enable biotech startups to hav... See more

Long sales cycles — Large buyers in infrastructure, industrial, and national security sectors have tended to buy through intermediaries, and typically only from large corporations who ‘check off all the boxes’, e.g. Prime contractors, Tier 1 suppliers, Consultancies etc. It is time to change that, and in addition to a small business grant program, ... See more

VCs have become used to 70–80%+ margins in software businesses. Well, that is hard,if not impossible, to achieve in hardware companies. So many entities along the value chain ‘touch’ the product that if everyone took such high margins, products would become too expensive to be useful. But 40–50% margins are not to be scoffed at, and we need to adju... See more